Marina Etcheverrigaray

Santa Fe De La Vera Cruz, S S3000ZAA, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Host cell protein profiling and immunogenicity assessment in E. coli-produced interferon beta.

Host cell protein profiling and immunogenicity assessment in E. coli-produced interferon beta.

Journal: Journal of pharmaceutical sciences

Published: January 30, 2026

Development of IFNβ-1a versions with reduced immunogenicity and full in vitro biological activity for the treatment of multiple sclerosis.

Development of IFNβ-1a versions with reduced immunogenicity and full in vitro biological activity for the treatment of multiple sclerosis.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 02, 2023

Specific sequence mutations in a long-lasting rhIFN-α2b version reduce in vitro and in vivo immunogenicity and increase in vitro protein stability.

Specific sequence mutations in a long-lasting rhIFN-α2b version reduce in vitro and in vivo immunogenicity and increase in vitro protein stability.

Journal: Heliyon

Published: August 31, 2022

Development, Production, and Characterization of Hepatitis B Subviral Envelope Particles as a Third-Generation Vaccine.

Development, Production, and Characterization of Hepatitis B Subviral Envelope Particles as a Third-Generation Vaccine.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 16, 2021

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases.

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 17, 2021

Pharmacokinetics Versus In Vitro Antiproliferative Potency to Design a Novel Hyperglycosylated hIFN-α2 Biobetter.

Pharmacokinetics Versus In Vitro Antiproliferative Potency to Design a Novel Hyperglycosylated hIFN-α2 Biobetter.

Journal: Pharmaceutical research

Published: September 17, 2020

Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats.

Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats.

Journal: Journal of virological methods

Published: May 21, 2020

Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein.

Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein.

Journal: Antiviral research

Published: April 01, 2020

Development of Magoh protein-overexpressing HEK cells for optimized therapeutic protein production.

Development of Magoh protein-overexpressing HEK cells for optimized therapeutic protein production.

Journal: Biotechnology and applied biochemistry

Published: December 18, 2019

Design and validation of an immuno-PCR assay for IFN-α2b quantification in human plasma.

Design and validation of an immuno-PCR assay for IFN-α2b quantification in human plasma.

Journal: Bioanalysis

Published: November 15, 2019

Production of Therapeutic Enzymes by Lentivirus Transgenesis.

Production of Therapeutic Enzymes by Lentivirus Transgenesis.

Journal: Advances in experimental medicine and biology

Published: September 05, 2019

The glycosylation of anti-rhIFN-α2b recombinant antibodies influences the antigen-neutralizing activity.

The glycosylation of anti-rhIFN-α2b recombinant antibodies influences the antigen-neutralizing activity.

Journal: Biotechnology letters

Published: June 30, 2019

Showing 1-12 of 33

Last Updated: 09/26/2026